ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.

ReWalk Robotics Ltd.

Lifeward, previously known as ReWalk Robotics, develops and manufactures innovative solutions to change the lives of people with physical limitations or disabilities.

Lifeward

ReWalk Personal Exoskeleton

AlterG Anti-Gravity Systems

ReWalk Germany

Introducing Lifeward, previously ReWalk Robotics.
Our mission at Lifeward is to relentlessly drive innovation to change the lives of individuals with physical limitations or disabilities. We are committed to delivering groundbreaking solutions that empower individuals to do what they love.
As a global market leader in pioneering life-changing solutions, our portfolio features innovative products including the ReWalk Exoskeleton, the ReStore Exo-Suit, the MYOLYN FES bikes, and our newest addition, the AlterG Anti-Gravity systems. We will continue to be the driving force to elevate the standard of care in overcoming physical limitations and disabilities.
It’s not just upward. It’s Lifeward.

We're thrilled to share some exciting news with you. ReWalk Robotics has undergone a significant transformation and is now officially known as Lifeward. This rebranding reflects our unwavering commitment to empowerment, innovation, and life-changing solutions.

🌐 About Lifeward: More than a name change, Lifeward is a movement—a force dedicated to guiding individuals toward trajectories they never thought possible. At our core is the belief that life is a continuous journey of discovery, growth, and fulfillment. Lifeward sees itself as a trusted ally committed to helping people pursue their life ambitions in the face of physical challenges and disabilities.

🚀 Join us on this Journey: We've spent over a decade leading the industry with groundbreaking innovations, achieving the seemingly impossible. Now, as Lifeward, we're ready to shape a future filled with innovation, empowerment, and shared success.

👉 Follow Lifeward on LinkedIn: Stay connected for updates, inspiring stories, and the latest developments. Your support has been our driving force, and we can't wait to embark on this exciting chapter together.

Lifeward CEO Larry Jasinski chats with the Big Biz Show about the origination, future and Medicare coverage of the ReWalk Personal Exoskeleton, as well as highlighting the benefits and uses of AlterG Anti-Gravity Systems products. Thanks for having us 👏🎙️

Interested in how the recent Medicare reimbursement decision affects access to personal exoskeletons? Our upcoming TechTalk will provide info on how new developments will help the SCI/D community gain access to this technology. 

Join us in collaboration with Lifeward on August 29th: https://lnkd.in/e8EcNb6N

Hello, August! ☀️ This month we will be bouncing across the country for some amazing events. Will you be in the area or attending? If so, come on by and say hello! 🤗

Smiles all around at the Lifeward Mid-Year Sales Meeting! Launched the new AlterG NEO, rolled out the ReWalk S.T.A.R.T program, and had a blast at the baseball game - with a cupcake in hand of course! #TeamLifeward

In case you missed it: Lifeward CEO Larry Jasinski joins the conversation on the Big Biz Show to discuss Medicare coverage for the ReWalk Personal Exoskeleton, and the positive impact this will have on patients moving forward.

Did you know? Lifeward is your home for more than Exoskeletons and Anti-Gravity Treadmills. We have also been a proud US distributor of the MyoCycle FES Bikes since 2020, and the MyoCycle is a perfect example of how our solutions can span the continuum of care, delivering functional and health benefits in clinical settings as well as in the home and community. Learn more about FES cycling with the MyoCycle here: https://lnkd.in/gqnkpmec

We can't wait to see you this month during one of our in-person events we will be attending. Whether it is in Florida at ATAF or in New Orleans cheering on for the National Veterans Wheelchair Games, come say hi and learn about Lifeward's suite of innovative solutions. See you there! 🤗

Did you see the news? Hello, NEO!  
The latest innovation from Lifeward, the AlterG NEO is designed to elevate your practice and revolutionize patient care with its all-new user-friendly design and the same patented DAP technology for precise and consistent unweighting that is the cornerstone of every AlterG system.

This all-new FDA-listed Anti-Gravity Treadmill comes with a 21-inch display for an enhanced user experience, with new software and a more user-friendly touchscreen for seamless navigation and maximum training efficiency. The brand-new motorized cockpit adjustment allows for precise, customizable height adjustments at the push of a button, and the 120V power source simplifies installation and integration into your practice. The 23-inch handrail width ensures comfort and support for patients and athletes of all body types, including neuro, ortho, and weight-loss applications. And the best part? The AlterG NEO comes at the most cost-effective pricing to date.

NEO helps you deliver results for your patients and clients at a price point that is right for you, on an Anti-Gravity treadmill that is right for them. Get ready to elevate your clinical practice - starting today! alterg.com

🌟 We're thrilled to unveil the AlterG NEO by Lifeward! 🌟 This FDA-listed Anti-Gravity Treadmill is designed to transform patient care with its advanced features: an expansive 21-inch display for an enhanced user experience, motorized cockpit adjustments for precise height adjustments at the push of a button, a 23-inch handrail for optimal comfort, and a convenient 120V power source. Best of all, it's more cost-effective than ever before, making the patented AlterG Anti-Gravity technology accessible to every practice. Discover how the AlterG NEO can elevate your training and patient care. alterg.com

	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
revenue	5.87M -	7.75M 32.10%	6.54M 15.58%	4.87M 25.55%	4.39M 9.85%	5.97M 35.81%	5.51M 7.63%	13.85M 151.39%
cost of revenue	5.13M -	4.65M 9.37%	3.72M 20.03%	2.15M 42.28%	2.20M 2.65%	3.06M 38.97%	3.61M 17.73%	9.40M 160.70%
gross profit	736K -	3.10M 321.33%	2.83M 8.90%	2.73M 3.50%	2.19M 19.70%	2.90M 32.62%	1.91M 34.38%	4.45M 133.75%
selling and marketing expenses					5.75M -	6.99M 21.53%	9.84M 40.74%	13.92M 41.45%
general and administrative expenses					4.98M -	5.63M 12.97%	7.13M 26.80%	9.99M 40.10%
selling general and administrative expenses	22.15M -	19.05M 13.99%	14.69M 22.89%	11.43M 22.22%	10.73M 6.06%	12.62M 17.56%	16.98M 34.53%	23.92M 40.89%
research and development expenses	9.03M -	6.04M 33.07%	7.35M 21.63%	5.35M 27.23%	3.46M 35.32%	2.94M 15.03%	4.03M 37.16%	4.15M 2.90%
other expenses
cost and expenses	36.31M -	29.75M 18.08%	25.76M 13.40%	18.92M 26.55%	16.40M 13.34%	18.62M 13.56%	24.61M 32.18%	37.47M 52.22%
operating expenses	31.18M -	25.09M 19.51%	22.04M 12.17%	16.77M 23.89%	14.19M 15.39%	15.56M 9.62%	21.01M 35.02%	28.07M 33.60%
interest expense	2.01M -	2.48M 23.43%	2.42M 2.30%	1.53M 36.88%	907K 40.72%
ebitda	-29.75M -	-21.35M 28.22%	-18.75M 12.17%	-13.73M 26.79%	-11.74M 14.46%	-12.43M 5.83%	-18.92M 52.27%	-21.90M 15.73%
operating income	-30.44M -	-21.99M 27.76%	-19.21M 12.63%	-14.05M 26.89%	-12.00M 14.55%	-12.65M 5.42%	-19.10M 50.94%	-23.61M 23.61%
depreciation and amortization	696K -	642K 7.76%	463K 27.88%	321K 30.67%	285K 11.21%	266K 6.67%	202K 24.06%	1.85M 814.36%
total other income expenses net	-2.06M -	-2.61M 26.57%	-2.47M 5.37%	-1.50M 39.33%	9K 100.60%	38K 322.22%	22K 42.11%	133K 504.55%
income before tax	-32.50M -	-24.60M 24.31%	-21.68M 11.86%	-15.54M 28.30%	-12.93M 16.85%	-12.64M 2.19%	-19.10M 51.10%	-22.14M 15.93%
income tax expense	3K -	119K 3,866.67%	-5K 104.20%	7K 240%	51K 628.57%	94K 84.31%	467K 396.81%	-12K 102.57%
net income	-32.50M -	-24.72M 23.95%	-21.68M 12.31%	-15.55M 28.25%	-12.98M 16.56%	-12.74M 1.85%	-19.57M 53.65%	-22.13M 13.10%
weighted average shs out	75.30K -	115.51K 53.40%	210.36K 82.11%	823.33K 291.40%	15.76M 1,814.78%	47.94M 204.06%	62.38M 30.13%	59.72M 4.26%
weighted average shs out dil	75.30K -	115.51K 53.40%	210.36K 82.11%	823.33K 291.40%	15.76M 1,814.78%	47.94M 204.06%	62.38M 30.13%	59.72M 4.26%
eps	-431.63 -	-213.98 50.43%	-103.04 51.85%	-18.89 81.67%	-0.82 95.66%	-0.27 67.07%	-0.31 14.81%	-0.37 19.35%
epsdiluted	-431.63 -	-213.98 50.43%	-103.04 51.85%	-18.89 81.67%	-0.82 95.66%	-0.27 67.07%	-0.31 14.81%	-0.37 19.35%

COM:GOLIFEWARD

Lifeward

Last Close

2.45

25/10 20:00

Market Cap

33.98M

Beta: -

Volume Today

17.05K

Avg: -

Preview